{"pub_date": "2016-01-05T00:00:00Z", "subsection_name": null, "lead_paragraph": "Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new United States drugs to its highest level in 19 years.", "print_page": "2", "document_type": "article", "byline": {"contributor": "", "person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "multimedia": [], "section_name": "Business Day", "headline": {"content_kicker": "Business Briefing", "print_headline": "F.D.A. Drug Approvals Climb to Highest Level Since 1996", "main": "F.D.A. Drug Approvals Climb to Highest Level Since 1996"}, "source": "The New York Times", "blog": [], "word_count": "163", "web_url": "http://www.nytimes.com/2016/01/05/business/fda-drug-approvals-climb-to-highest-level-since-1996.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "Brief", "snippet": "Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new United States drugs to its highest level in 19 years.", "_id": "568b050a38f0d85e74bd0b3e", "abstract": "Food and Drug Administration approved 45 drugs with never-before-sold ingredients in 2015, highest number since 1996.", "keywords": [{"rank": "1", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "2", "name": "organizations", "value": "Food and Drug Administration", "is_major": "Y"}]}